Dinesh Ph D Patel V sold $4.7M of PTGX
President and CEO at Protagonist Therapeutics, Inc. 100,000 shares at an average of $46.81, traded Nov 25, 2024, filed Nov 27, 2024.
Score components
- +25RoleCEO
- +25Trade size$4.7M at market
- +5Share of holdings soldSold 19% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -13.3%, 3m -19.6%, 6m +1.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-24-123806, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 25, 2024 | SOpen-market sale Common Stock | -78,520 | $46.96 | $3.7M | 435,208 | Nov 27, 2024 |
| Nov 25, 2024 | GGift Common Stock | -7,000 | $0.00 | $0 | 428,208 | Nov 27, 2024 |
| Nov 25, 2024 | MOption exercise Common Stock | +1,727 | $21.58 | $37k | 429,935 | Nov 27, 2024 |
| Nov 26, 2024 | SOpen-market sale Common Stock | -21,480 | $46.25 | $993k | 408,455 | Nov 27, 2024 |
| Nov 25, 2024 | MOption exercise Stock Option (right to buy)derivative | -1,727 | $0.00 | $0 | 318,273 | Nov 27, 2024 |
Related signals
Other insiders at Protagonist Therapeutics, Inc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 22Weak | Protagonist Therapeutics, Inc | Asif Ali Chief Financial Officer | $8.3M 58,629 shares | -50% | |
| 20Weak | Protagonist Therapeutics, Inc | Dinesh Ph D Patel V President and CEO | $18M 125,000 shares | -22% | |
| 42Moderate | PTGXsell Protagonist Therapeutics, Inc | Asif Ali Chief Financial Officer | $2.6M 24,765 shares | -29% | |
| 42Moderate | PTGXsell Protagonist Therapeutics, Inc | Asif Ali Chief Financial Officer | $3.8M 46,203 shares | -43% | |
| 43Moderate | PTGXsell Protagonist Therapeutics, Inc | Asif Ali Chief Financial Officer | $708k 8,588 shares | -10% | |
| 28Weak | PTGXsell Protagonist Therapeutics, Inc | Arturo Molina Md Chief Medical Officer | $230k 2,712 shares | -3% | |
| 25Weak | Protagonist Therapeutics, Inc | William D. Waddill director | $979k 12,000 shares | -70% | |
| 18Weak | Protagonist Therapeutics, Inc | William D. Waddill director | $257k 4,000 shares | -44% | |
| 18Weak | Protagonist Therapeutics, Inc | William D. Waddill director | $237k 4,000 shares | -30% | |
| 44Moderate | PTGXsell Protagonist Therapeutics, Inc | Dinesh Ph D Patel V President and CEO | $571k 10,415 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.